The Stimulant Balance: Treating ADHD in the Context of Substance Use

Event description
Funded by BSAS
Yes
Introductory level
Yes
Event format
Training (skill building)

Virtual meeting

Via Zoom

Description

This training will provide participants with the tools for identifying ADD/ADHD among patients. Commonly used stimulant medications for treating ADD/ADHD will be covered, including their importance, potential side effects, and treatment considerations. Participants will gain tools for evaluating the effectiveness of ADHD treatment interventions.

Intended audience

Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.

Speakers

Megan (Meg) Hudson, MSN, PMHNP-BC (she/her)

Meg is a clinical nurse educator with Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance and a psychiatric mental health nurse practitioner at Boston Medical Center. Prior to obtaining her MSN, she worked as a nurse care manager in the Stimulant Treatment and Recovery Clinic (START) clinic, integrating harm reduction, infectious disease treatment, medical addiction groups, and co-management of stimulant use disorders and mental health conditions. Her clinical expertise includes harm reduction, low barrier treatment, complex care management, early identification and management of acute and persistent stimulant-induced psychosis. She earned both her BSN and MSN from Regis College.

Objectives

At the end of this training, participants will have the knowledge necessary to:

  1. Recognize the use of screening tools to identify patients with ADD/ADHD.
  2. Recognize the importance of treating ADD/ADHD in patients with substance use disorder (SUD).
  3. Describe at least two commonly used stimulant medications in patients with SUD, including potential side effects and treatment considerations.
  4. Identify strategies to evaluate the effectiveness of treatment interventions for ADHD.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,710,074.00 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Accreditation information

Please read the Accreditation Information section of the training page to learn about the requirements for receiving credit or a certificate of completion.

 

Audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Credential(s) Type of Continuing Education Credit (optional) Number of credits/hours/units etc. offered
Details provided on registration page.
Details provided on registration page.
Details provided on registration page.
Details
Event date
to
Attendance mode
Online
Cost
FREE
Contact
Organization
Boston Medical Center Grayken Center for Addiction Training & Technical Assistance
Email